Ashford B - Search Results

1

Micro RNA Dysregulation in Keratinocyte Carcinomas: Clinical Evidence, Functional Impact, and Future Directions.

Conley J, Genenger B, Ashford B, Ranson M. Conley J, et al. Among authors: ashford b. Int J Mol Sci. 2024 Aug 3;25(15):8493. doi: 10.3390/ijms25158493. Int J Mol Sci. 2024. PMID: 39126067 Free PMC article. Review.

2

Comprehensive Mutational and Phenotypic Characterization of New Metastatic Cutaneous Squamous Cell Carcinoma Cell Lines Reveal Novel Drug Susceptibilities.

Perry J, Ashford B, Thind AS, Gauthier ME, Minaei E, Major G, Iyer NG, Gupta R, Clark J, Ranson M. Perry J, et al. Among authors: ashford b. Int J Mol Sci. 2020 Dec 15;21(24):9536. doi: 10.3390/ijms21249536. Int J Mol Sci. 2020. PMID: 33333825 Free PMC article.

3

Ex vivo therapeutic screening of metastatic cSCC: A review of methodological considerations for clinical implementation.

Conley J, Perry JR, Ashford B, Ranson M. Conley J, et al. Among authors: ashford b. Exp Dermatol. 2024 Apr;33(4):e15089. doi: 10.1111/exd.15089. Exp Dermatol. 2024. PMID: 38659312 Review.

4

Circulating tumour cells in regionally metastatic cutaneous squamous cell carcinoma: A pilot study.

Morosin T, Ashford B, Ranson M, Gupta R, Clark J, Iyer NG, Spring K. Morosin T, et al. Among authors: ashford b. Oncotarget. 2016 Jul 26;7(30):47111-47115. doi: 10.18632/oncotarget.9946. Oncotarget. 2016. PMID: 27302928 Free PMC article.

5

Reviewing the genetic alterations in high-risk cutaneous squamous cell carcinoma: A search for prognostic markers and therapeutic targets.

Ashford BG, Clark J, Gupta R, Iyer NG, Yu B, Ranson M. Ashford BG, et al. Head Neck. 2017 Jul;39(7):1462-1469. doi: 10.1002/hed.24765. Epub 2017 Apr 3. Head Neck. 2017. PMID: 28370784 Review.

6

PD-L1 expression predicts longer disease free survival in high risk head and neck cutaneous squamous cell carcinoma.

Roper E, Lum T, Palme CE, Ashford B, Ch'ng S, Ranson M, Boyer M, Clark J, Gupta R. Roper E, et al. Among authors: ashford b. Pathology. 2017 Aug;49(5):499-505. doi: 10.1016/j.pathol.2017.04.004. Epub 2017 Jun 27. Pathology. 2017. PMID: 28666643

7

Thulium oxide nanoparticles as radioenhancers for the treatment of metastatic cutaneous squamous cell carcinoma.

Perry J, Minaei E, Engels E, Ashford BG, McAlary L, Clark JR, Gupta R, Tehei M, Corde S, Carolan M, Ranson M. Perry J, et al. Phys Med Biol. 2020 Nov 5;65(21):215018. doi: 10.1088/1361-6560/abaa5d. Phys Med Biol. 2020. PMID: 32726756

8

Gene expression profiling of perineural invasion in head and neck cutaneous squamous cell carcinoma.

Eviston TJ, Minaei E, Mueller SA, Ahmadi N, Ashford B, Clark JR, West N, Zhang P, Gupta R, Ranson M. Eviston TJ, et al. Among authors: ashford b. Sci Rep. 2021 Jun 23;11(1):13192. doi: 10.1038/s41598-021-92335-4. Sci Rep. 2021. PMID: 34162930 Free PMC article.

9

Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma.

Minaei E, Mueller SA, Ashford B, Thind AS, Mitchell J, Perry JR, Genenger B, Clark JR, Gupta R, Ranson M. Minaei E, et al. Among authors: ashford b. Front Oncol. 2022 Apr 11;12:835929. doi: 10.3389/fonc.2022.835929. eCollection 2022. Front Oncol. 2022. PMID: 35480116 Free PMC article.

10

A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review).

Genenger B, Perry JR, Ashford B, Ranson M. Genenger B, et al. Among authors: ashford b. Discov Oncol. 2022 Jun 6;13(1):42. doi: 10.1007/s12672-022-00510-4. Discov Oncol. 2022. PMID: 35666359 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters